This website is intended for US residents 18 years of age and older

Evaluating All Potential Hodgkin Lymphoma Treatment Options

For Katherine A., a significant part of her Hodgkin lymphoma treatment decision-making process was talking to her oncologist about all available treatment options including joining a clinical trial. Find out why she decided to take this route for treatment and what helped her feel confident in her choice. 

Ask your doctor about recommended treatment options for Hodgkin lymphoma, including important information about safety and side effects, and download a guide for Questions to Ask Your Doctor about Hodgkin lymphoma here.

The stories featured on this page reflect each patient's own unique experience with Hodgkin lymphoma. Information shared in these videos is not intended to replace discussions with your doctor.

Katherine A.

Katherine A.

Diagnosed at 30


When Katherine was diagnosed with Stage 4 classical Hodgkin lymphoma, she put her background in microbiology to a new use – researching the disease and all the potential treatment options. Ultimately, after researching Hodgkin lymphoma treatment, she and her oncologist worked together and decided on treatment through a clinical trial.

Hodgkin Lymphoma
Treatment Discussion

Watch Next


The Importance of Emotional Support Through Your Diagnosis


Discussing Hodgkin Lymphoma Treatment Options with Your Oncologist
Considering Clinical Trials During Cancer Treatment


Preparing for Treatment Conversations with Your Oncologist
Considering Clinical Trials During Cancer Treatment


Navigating Hodgkin Lymphoma Information Overload After Diagnosis
Considering Clinical Trials During Cancer Treatment



This site is intended only for U.S. residents. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. Logos are the trademarks of their respective owners. All decisions regarding patient care must be made with a healthcare provider considering the unique characteristics of the patient.

Copyright © 2024 Pfizer Inc.All rights reserved.US-DIS-24-105-MT

Follow us: